PROGRAM CHAIR
Mile Brujic, OD, FAAO
Partner, PremierVision Group
Bowling Green, Ohio
FACULTY SPEAKERS
Jessilin Quint, OD, MBA, MS, FAAO
Smart Eye Care
Augusta, Maine
Cecelia Koetting, OD, FAAO, DipABO
Assistant Professor, Ophthalmology
University of Colorado School of Medicine
Aurora, Colorado
PROGRAM OVERVIEW
This enduring symposium is designed to enhance the knowledge and clinical competence of optometrists in the diagnosis and management of Demodex blepharitis. Expert faculty will review clinical characteristics, differential diagnosis, and evidence-based treatments, with an emphasis on recognizing pathognomonic signs and distinguishing Demodex blepharitis from other ocular surface conditions. Participants will examine the latest evidence supporting mechanism-directed therapies and explore practical approaches to incorporating pharmacologic treatments, patient counseling, and longitudinal follow-up into clinical practice. Case-based small-group discussions and audience polling will engage learners in applying key concepts to realistic clinical scenarios and addressing common challenges in diagnosis, treatment selection, adherence, and ongoing disease management.
TARGET AUDIENCE
This educational activity will be designed to meet the educational needs of optometrists involved in the diagnosis and management of patients with Demodex blepharitis.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Differentiate Demodex blepharitis from other ocular surface conditions through targeted history-taking and slit-lamp examination, with emphasis on recognition of pathognomonic signs such as collarettes and characteristic symptom patterns
- Apply evidence-based, mechanism-directed treatment strategies that address underlying mite infestation and support timely, effective resolution of clinical signs and symptoms
- Implement patient-centered counseling and longitudinal management approaches that address symptom burden, functional impairment, treatment adherence, and risk of recurrence to optimize visual outcomes and QoL
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in this enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
COPE CREDIT DESIGNATION
Med Learning Group designates this asynchronous activity for a maximum of 1.0 COPE credit hour.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Mile Brujic, OD, FAAO | Serves as a consultant for Apellis, AbbVie, Azura Ophthalmics, Bruder, Bausch + Lomb, Knack Global, Dompé, Dopa Vision, EyePromise, Glaukos, MDE Lite, Nordic Pharma, Orasis, and Radius XR. He serves as a speaker for Apellis, Alcon, Bausch + Lomb, Dompé, Nordic Pharma, Orasis, Tarsus, and Tenpoint Therapeutics. He has contracted research with Tarsus and Mediprint Ophthalmics. |
| Jessilin Quint, OD, MBA, MS, FAAO | Serves as a consultant for Alcon, Bausch + Lomb, AbbVie, Dompé, LENZ Therapeutics, Glaukos, Eyenovia, Orasis Pharmaceuticals, BioTissue, Oyster Point Pharma, and Sun Pharmaceutical Industries. She serves as a speaker for Alcon, Bausch + Lomb, AbbVie, Dompé, and LENZ Therapeutics. |
| Cecelia Koetting, OD, FAAO, DipABO | Serves as a consultant for Allergan/AbbVie, Orasis, Tarsus, Alcon, Glaukos, Dompé, Bausch + Lomb, Myze, Azura Ophthalmics, BlinkJoy, PRN/EyePromise, ScienceBased Health, NuLids, Vital Tears, Topcon, Movu, Tenpoint Therapeutics, Scope Ophthalmics, and BioTissue. She serves as a speaker for Allergan/AbbVie, Orasis, Tarsus, Alcon, Dompé, Bausch + Lomb, and Harrow. She has received research funding from Orasis, Tarsus, and Bausch + Lomb. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Russie Allen, M.M, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Sarah Milano, RN, MSN, has nothing to disclose
- Lauren Scott, MS, Medical Director for Med Learning Group, has nothing to disclose.
- Heather Gee, Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: October 16, 2026
EXPIRATION DATE: October 16, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
